Search

Displaying results 8301 - 8310 of 8695 in total
  1. Drug

    Ragaglitazar

    go.drugbank.com/drugs/DB06533
    Experimental

  2. Drug

    Robalzotan

    go.drugbank.com/drugs/DB06538
    Experimental

    Categories: Serotonin Receptor Antagonists, Serotonin 5-HT1 Receptor Antagonists
  3. Drug

    Gavilimomab

    go.drugbank.com/drugs/DB06545
    Investigational

  4. Drug

    Fispemifene

    go.drugbank.com/drugs/DB06640
    Investigational

  5. Drug

    Priralfinamide

    go.drugbank.com/drugs/DB06649
    Investigational

  6. Drug

    Almorexant

    go.drugbank.com/drugs/DB06673
    Investigational

  7. Drug

    rhGAD65

    go.drugbank.com/drugs/DB04963
    Investigational

    rhGAD65 (recombinant human glutamic acid decarboxylase) is a vaccine being developed to treat insulin dependent type 1 diabetes.

  8. Drug

    PSN357

    go.drugbank.com/drugs/DB05044
    Experimental

    PSN357 is a glycogen phosphorylase inhibitor (GPI), which is designed to rapidly lower blood glucose levels by preventing glycogen breakdown to glucose in the liver.

  9. Drug

    ARX201

    go.drugbank.com/drugs/DB05082
    Investigational

    ARX201 (PEG-ahGH) is a recombinant form of human growth hormone that has been modified using Ambrx’s patented ReCODE™ technology to achieve precise spatial positioning of the site of polyethylene glycol (PEG) attachment to human growth h...

  10. Drug

    APD668

    go.drugbank.com/drugs/DB05166
    Experimental

    APD668 is a novel, highly potent and orally active glucose-dependent insulinotropic receptor (GDIR) agonist intended to more efficiently stimulate insulin release by beta cells in response to elevated